Stock Information
Ascendis Pharma A/S (ASND)
Ticker Symbol: ASND
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $14,266.42 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -3.7369
Revenue (TTM): $11.77 M
Dividend Yield: N/A%
ROE: -257.14%
Latest News
-
Trading Halt: Halt status updated at 6:15:00 PM ET: Quotation Resumption: News and Resumption Times
Fri, Feb 27, 2026 7:15 PM
-
Ascendis Pharma Receives FDA Approval For YUVIWEL For Children With Achondroplasia Aged 2 Years and Older; Commercial Availability Expected During Early Part Of Q2 2026; Rare Pediatric Disease Priority Review Voucher Granted In Connection With Approval
Fri, Feb 27, 2026 7:03 PM
-
Trading Halt: Halted at 4:26:29 p.m. ET - Trading Halt: Halt News Pending
Fri, Feb 27, 2026 5:26 PM
Key Financials
Financial data not available
